MX2009012714A - Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica. - Google Patents

Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.

Info

Publication number
MX2009012714A
MX2009012714A MX2009012714A MX2009012714A MX2009012714A MX 2009012714 A MX2009012714 A MX 2009012714A MX 2009012714 A MX2009012714 A MX 2009012714A MX 2009012714 A MX2009012714 A MX 2009012714A MX 2009012714 A MX2009012714 A MX 2009012714A
Authority
MX
Mexico
Prior art keywords
heteroaryl
imidazole
novel
thiones
cosmetology
Prior art date
Application number
MX2009012714A
Other languages
English (en)
Inventor
Jean-Guy Boiteau
Corinne Millois Barbuis
Karine Bouquet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2009012714A publication Critical patent/MX2009012714A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos de 4-heteroaril-imidazol-2-tionas que responden a la fórmula general (I) siguiente, a las composiciones que los contienen, 5 a su procedimiento de preparación y a su utilización en composiciones farmacéuticas o cosméticas destinadas al tratamiento o a la prevención de trastornos pigmentarios. (ver fórmula I).
MX2009012714A 2007-06-05 2008-06-04 Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica. MX2009012714A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755473A FR2917089B1 (fr) 2007-06-05 2007-06-05 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
PCT/FR2008/050995 WO2008152332A1 (fr) 2007-06-05 2008-06-04 Nouveaux 4-héteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procédé de préparation et leur utilisation en médecine humaine ainsi qu'en cosmétique

Publications (1)

Publication Number Publication Date
MX2009012714A true MX2009012714A (es) 2009-12-08

Family

ID=38962668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012714A MX2009012714A (es) 2007-06-05 2008-06-04 Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.

Country Status (12)

Country Link
US (1) US7989483B2 (es)
EP (1) EP2164845A1 (es)
JP (1) JP2010529097A (es)
KR (1) KR20100028090A (es)
CN (1) CN101679388A (es)
AR (1) AR066871A1 (es)
AU (1) AU2008263667A1 (es)
CA (1) CA2688237A1 (es)
FR (1) FR2917089B1 (es)
MX (1) MX2009012714A (es)
RU (1) RU2009149608A (es)
WO (1) WO2008152332A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
CN116854267B (zh) * 2023-09-01 2024-01-02 杭州尚善若水环保科技有限公司 一种用于反渗透膜的阻垢剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
JPH05124923A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JPH05132422A (ja) * 1991-04-09 1993-05-28 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
US7115748B2 (en) * 2004-12-07 2006-10-03 Allergan, Inc. Method of making imidazole-2-thiones
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Also Published As

Publication number Publication date
US20100144813A1 (en) 2010-06-10
KR20100028090A (ko) 2010-03-11
AR066871A1 (es) 2009-09-16
EP2164845A1 (fr) 2010-03-24
US7989483B2 (en) 2011-08-02
FR2917089B1 (fr) 2009-07-17
JP2010529097A (ja) 2010-08-26
WO2008152332A1 (fr) 2008-12-18
AU2008263667A1 (en) 2008-12-18
FR2917089A1 (fr) 2008-12-12
RU2009149608A (ru) 2011-07-20
CN101679388A (zh) 2010-03-24
CA2688237A1 (fr) 2008-12-18

Similar Documents

Publication Publication Date Title
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
MX367623B (es) 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX341211B (es) Sintesis de un nuevo antioxidante de nitroxido y metodos de uso en composiciones cosmeticas y dermatologicas.
WO2009141541A3 (fr) Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
TW200738659A (en) Novel compounds
MX2009013131A (es) Moduladores de gamma secretasa.
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
UA101393C2 (ru) КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ
WO2007049158A3 (en) Ppar modulating biaromatic compounds
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.
SI2373310T1 (sl) Nove spojine 4- (heterocikloalkil) benzen-1, 3- diola kot inhibitorji tirosinaze, postopek njihove priprave in njihova uporaba v humani medicini in tudi v kozmetiki
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MY146802A (en) Novel drugs for treating respiratory diseases
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
MX2013002295A (es) 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2005056510A3 (en) Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics

Legal Events

Date Code Title Description
FG Grant or registration